1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with 6-ketoprostaglandin f1 alpha in 82 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (6-ketoprostaglandin f1 alpha) | Trials (6-ketoprostaglandin f1 alpha) | Recent Studies (post-2010) (6-ketoprostaglandin f1 alpha) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 4,832 | 294 | 150 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 30 (36.59) | 18.7374 |
1990's | 51 (62.20) | 18.2507 |
2000's | 1 (1.22) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Giessler, C; Mentz, G; Mentz, P; Mest, HJ | 1 |
Henderson, WR; Hodson, WA; Jackson, JC; Juul, SE; Murphy, JH; Standaert, TA; Truog, WE | 1 |
Bergmann, R; Brecht, HM; Gokel, M; Hammer, C; Saumweber, DM; Zellner, C | 1 |
Flohé, S; Heinrich, PC; Hörstmann-Jungemann, K; Kirkpatrick, CJ; Klosterhalfen, B; Offner, F; Vogel, P | 1 |
Levine, L | 5 |
Davenport, NJ; Feuerstein, GZ; Goldstein, RE | 1 |
Becker, WM; Schade, U; Schaubschläger, WW; Schlaak, M; Zabel, P | 1 |
Braquet, P; Filep, JG; Mózes, T | 1 |
Adler, L; Hageman, JR; Hickman, AR; Silver, RK | 1 |
Peskar, BA; Pritze, S; Simmet, T | 1 |
Fu, J; Li, PS; Yu, HP | 1 |
Blasevich, M; Galli, C; Petroni, A; Visioli, F | 1 |
Berti, F; De Angelis, L; Galli, G; Magni, F; Rossoni, G | 1 |
Imanishi, M; Miura, K; Okumura, M; Shimmen, T; Yamamoto, K; Yamanaka, S; Yamashita, Y; Yukimura, T | 1 |
Bergmann, R; Brecht, HM; Gokel, M; Hammer, C; Saumweber, DM | 1 |
Altavilla, D; Arena, A; Campo, GM; Caputi, AP; Santoro, G; Squadrito, F; Sturniolo, R | 1 |
Filep, JG; Hermán, F; Magyar, K | 1 |
Hamano, S; Ikeda, S; Kikuchi, S; Kojima, M; Komatsu, H; Kusama, H; Okegawa, T; Takehana, Y | 1 |
Andrus, CH; Deshpande, YG; German, D; Kaminski, DL | 1 |
Baum, TD; Feldman, HS; Fink, MP; Heard, SO; Latka, CA | 1 |
Kondo, K; Takayasu-Okishio, M; Terashita, Z | 1 |
Dubbin, PN; Dusting, GJ; Harris, T; Stewart, AG | 1 |
Mitchell, MD; Weinreb, RN | 1 |
Hampel, G; Jaffe, EA; Watanabe, K; Weksler, BB | 1 |
Laplante, C; Marceau, F; Tremblay, B | 1 |
Moore, JN; Morris, DD | 1 |
Bachelet, M; Béréziat, G; Kadiri, C; Masliah, J; Vargaftig, BB | 1 |
Phillips, WA; Stewart, AG | 1 |
Stewart, AG | 1 |
Dembinska-Kiec, A; Muller, MK; Peskar, BA; Peskar, BM | 1 |
Borgeat, P; Braquet, P; Harczy, M; Maclouf, J; Pradelles, P; Sirois, P | 1 |
Caravella, SJ; Clark, DA; McNeill, H; Miller, MJ; Mullane, KM | 1 |
Bradley, LM; Czaja, JF; Feuerstein, G; Goldstein, RE | 1 |
Apprill, P; Ashton, J; Buja, LM; Campbell, WB; Raheja, S; Schmitz, JM; Tilton, G; Willerson, JT | 1 |
D'Humières, S; Russo-Marie, F; Vargaftig, BB | 1 |
Vandongen, R | 1 |
Ezra, D; Feuerstein, G; Goldstein, RE; Hayes, E; Ramwell, PW | 1 |
Lefort, J; Pretolani, M; Vargaftig, BB | 1 |
Becker, K; Förster, W | 1 |
Beilin, LJ; Codde, J; Croft, KD; Vandongen, R | 1 |
Kobayashi, T; Koyama, S; Kusama, S; Toyofuku, T | 1 |
Aliaga, M; Barbara, M; Bruniquel, F; Couzinier, JP; Delhon, A; Puech, L; Tarayre, JP; Tisne-Versailles, J | 1 |
Codde, JP; Croft, KD; McGowan, HM; Vandongen, R | 1 |
Czaja, JF; Ezra, D; Feuerstein, G; Goldstein, RE; Laurindo, FR; Snyder, F | 1 |
Bruniquel, F; Couzinier, JP; Delhon, A; Puech, L; Tarayre, JP; Tisne-Versailles, J | 1 |
de Gaetano, G; Dejana, E; Finesso, M; Gorio, A; Languino, LR; Prosdocimi, M; Tessari, F | 1 |
Abdel-Latif, AA; Yousufzai, SY | 1 |
Henson, PM; Murphy, RC; Reeves, JT; Simpson, J; Voelkel, NF; Worthen, S | 1 |
Hamasaki, Y; Mojarad, M; Saga, T; Said, SI; Tai, HH | 1 |
Apffel, D; Benveniste, J; Bessin, P; Bonnet, J; Desgroux, L; Pelas, I; Soulard, C | 1 |
Antunes, E; Cirino, G; de Nucci, G; Donato, JL; Faro, R; Hyslop, S; Landucci, EC; Marangoni, S; Oliveira, B | 1 |
Giessler, C; Heinroth-Hoffmann, I; Meissner, N; Mest, HJ; Pönicke, K | 1 |
Keuskamp, ZJ; Madretsma, GS; Van Dijk, JP; Zijlstra, FJ | 1 |
Kirkpatrick, CJ; Klinge, U; Klosterhalfen, B; Mittermayer, C; Schumpelick, V; Töns, C | 1 |
Fan, TP; Gresham, GA; Guard, S; Hu, DE; Watling, KJ | 1 |
Chandel, B; Deshpande, Y; Kaminski, DL; Kulkarni, A; Longo, WE; Niehoff, M; Polities, G; Vernava, AM | 1 |
Eliakim, R; Karmeli, F; Okon, E; Rachmilewitz, D | 1 |
Okano, S; Tagawa, M; Urakawa, N | 1 |
Hirayama, K; Matsuzaki, T; Noguchi, K; Ojiri, Y; Sakanashi, M; Shiroma, N | 1 |
Chandel, B; Deshpande, Y; Kaminski, DL; Li, AP; Longo, WE; Stratton, MD; Vernava, AM | 1 |
Imai, T; Imai, Y; Kawano, T; Miyasaka, K; Okuyama, K; Takata, M | 1 |
Blasevich, M; Colombo, C; Galella, G; Galli, C; Papini, N; Petroni, A; Salami, M | 1 |
Cabré, F; Carganico, G; Gutiérrez, M; Mauleón, D; Suesa, N; Tost, D; Ucedo, P | 1 |
Fukuoka, T; Nakajima, Y; Nakano, H | 1 |
Levine, BA; Olson, MS; Zhou, W | 1 |
Erl, W; Kruse, HJ; Sellmayer, A; Weber, C; Weber, PC | 1 |
Goff, AK; Slama, H; Vaillancourt, D | 1 |
Johnson, LW; Kruse-Elliott, KT; Olson, NC | 1 |
Bartula, L; Kadesky, K; Kalley-Taylor, B; Myers, SI; Riva, A; Turnage, R | 1 |
Brasch, F; Featherstone, RL; Klein, T; Müller, KM; Nüsing, R; Uhlig, S; Ullrich, V; von Bethmann, A; Wendel, A | 1 |
Ando, H; Kobayashi, K; Nakatani, T; Sakamoto, Y | 1 |
Koie, H; Koyama, M; Satoh, K; Suzuki, S; Takamatsu, S; Yoshida, H | 1 |
Hauptmann, S; Kirkpatrick, CJ; Klosterhalfen, B; Küpper, W; Offner, FA; Tietze, L; Töns, C | 1 |
Korth, RM | 1 |
Alper, CM; Burckart, GJ; Diven, WF; Doyle, WJ; Evans, RW; Jaffe, R | 1 |
Li, Y; Si, Y; Wang, F | 1 |
Denizot, Y; Feiss, P; Nathan, N | 1 |
Kolaczkowska, E; Plytycz, B; Seljelid, R; Shahzidi, S; van Rooijen, N | 1 |
82 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 6-ketoprostaglandin f1 alpha
Article | Year |
---|---|
Interactions of prostanoids with the platelet activating factors.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Azepines; Guinea Pigs; Heart; Iloprost; In Vitro Techniques; Indomethacin; Myocardial Contraction; Perfusion; Platelet Activating Factor; Prostaglandins; Sulfonamides; Thromboxane A2; Thromboxane B2; Triazoles | 1992 |
Acute changes in vasoactive lipid mediators in experimental hyaline membrane disease.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acids; Fetal Blood; High-Frequency Ventilation; Humans; Hyaline Membrane Disease; Infant, Newborn; Lung; Macaca nemestrina; Platelet Activating Factor; Respiration, Artificial; SRS-A; Thromboxane B2; Time Factors | 1992 |
Studies on xenograft rejection: the role of leukocytes and prostaglandins and their modulation by the hetrazepine WEB 2086BS.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Azepines; Erythrocyte Count; Graft Rejection; Hemagglutinins; Hemoperfusion; Humans; Kidney Transplantation; Leukocytes; Platelet Activating Factor; Swine; Thromboxane B2; Transplantation, Heterologous; Triazoles | 1992 |
Time course of various inflammatory mediators during recurrent endotoxemia.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Inflammation; Interleukin-6; Lipopolysaccharides; Platelet Activating Factor; Pulmonary Wedge Pressure; Shock, Septic; Swine; Thromboxane B2; Time Factors; Tumor Necrosis Factor-alpha | 1992 |
Effects of okadaic acid on agonist-stimulated PGI2 production by rat liver cells (the C-9 cell line).
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Arachidonic Acids; Cell Line; Ethers, Cyclic; Kinetics; Liver; Okadaic Acid; Phosphoprotein Phosphatases; Platelet Activating Factor; Prostaglandins F; Radioimmunoassay; Rats; Tetradecanoylphorbol Acetate; Thrombin | 1991 |
In vivo enhancement of platelet activating factor-induced prostacyclin production by OKY-046, a selective inhibitor of thromboxane A2 synthase.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Pressure; Dose-Response Relationship, Drug; Epoprostenol; Female; Heart Rate; Hemodynamics; Male; Methacrylates; Platelet Activating Factor; Swine; Thromboxane A2; Thromboxane-A Synthase; Vascular Resistance | 1991 |
Release of mediators from human gastric mucosa and blood in adverse reactions to benzoate.
Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Adult; Aged; Asthma; Benzoates; Benzoic Acid; Dermatitis, Atopic; Endoscopy, Gastrointestinal; Female; Food Additives; Gastric Mucosa; Histamine; Histamine Release; Humans; Male; Middle Aged; Monocytes; Platelet Activating Factor; Urticaria | 1991 |
Interactions between platelet-activating factor and prostanoids during mesenteric ischemia-reperfusion-induced shock in the anesthetized dog.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Dinoprost; Diterpenes; Dogs; Ginkgolides; Hemodynamics; Indomethacin; Lactones; Male; Mesenteric Arteries; Mesenteric Veins; Platelet Activating Factor; Prostaglandins; Reperfusion Injury; Shock; Thromboxane B2 | 1991 |
Anticardiolipin antibody-positive serum enhances endothelial cell platelet-activating factor production.
Topics: 6-Ketoprostaglandin F1 alpha; Antibodies; Antiphospholipid Syndrome; Calcimycin; Cardiolipins; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Platelet Activating Factor; Umbilical Veins | 1991 |
Effect of platelet-activating factor on porcine pulmonary blood vessels in vitro.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Azepines; Calcimycin; Diterpenes; Eicosanoids; Ginkgolides; In Vitro Techniques; Lactones; Male; Muscle Contraction; Muscle, Smooth, Vascular; Platelet Activating Factor; Platelet Aggregation Inhibitors; Pulmonary Circulation; Radioimmunoassay; SRS-A; Swine; Thromboxane B2; Triazoles | 1991 |
[Experimental and clinical study of activated platelet in allergic asthma].
Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Adult; Animals; Asthma; Diterpenes; Female; Ginkgolides; Guinea Pigs; Humans; Lactones; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Platelet Factor 4 | 1991 |
Arachidonic acid cyclo and lipoxygenase pathways in astroglial cells.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Arachidonic Acids; Astrocytes; Calcimycin; Cells, Cultured; Diglycerides; Eicosanoids; Fatty Acids, Nonesterified; Hydroxyeicosatetraenoic Acids; Lipoxygenase; Platelet Activating Factor; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Rats; Thromboxane B2 | 1991 |
Opposite effects of PGI2 and PAF generated during acute myocardial ischemia in the perfused rabbit heart.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Coronary Disease; Epoprostenol; Fibrinolytic Agents; In Vitro Techniques; Myocardial Reperfusion Injury; Platelet Activating Factor; Polydeoxyribonucleotides; Rabbits | 1991 |
Regulation of arachidonic acid metabolism by phenylarsine oxide.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acids; Arsenicals; Bradykinin; Calcimycin; Cell Line; Epoprostenol; Kinetics; Liver; Lymphoma; Mice; Platelet Activating Factor; Rats | 1991 |
Renal and femoral vascular responses to endothelin-1 in dogs: role of prostaglandins.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Pressure; Dinoprostone; Dogs; Dose-Response Relationship, Drug; Endothelins; Female; Femoral Artery; Heart Rate; Infusions, Intra-Arterial; Infusions, Intravenous; Kidney; Male; Platelet Activating Factor; Prostaglandins; Pyridinium Compounds; Renal Circulation; Time Factors; Vasoconstriction | 1991 |
The involvement of platelet-activating factor in hyperacute xenogeneic rejection and its modulation by the PAF-antagonist WEB 2086BS.
Topics: 6-Ketoprostaglandin F1 alpha; Acute Disease; Animals; Azepines; Female; Graft Rejection; Hemoperfusion; Humans; Kidney Transplantation; Male; Platelet Activating Factor; Swine; Thromboxane B2; Transplantation, Heterologous; Triazoles | 1991 |
Actions of vanadate on arachidonic acid metabolism by cells in culture.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta; Arachidonic Acids; Calcimycin; Cattle; Cell Line; Cells, Cultured; Kinetics; Liver; Lyngbya Toxins; Muscle, Smooth, Vascular; Norepinephrine; Platelet Activating Factor; Rats; Serotonin; Vanadates | 1991 |
Platelet activating factor involvement in splanchnic artery occlusion shock in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arterial Occlusive Diseases; Blood Pressure; Furans; Leukocyte Count; Leukopenia; Macrophages; Male; Phagocytosis; Platelet Activating Factor; Radioimmunoassay; Rats; Rats, Inbred Strains; Shock; Splanchnic Circulation; Thromboxane B2; Tumor Necrosis Factor-alpha | 1991 |
In vivo antiaggregatory action of platelet-activating factor in beagle dogs: role for prostacyclin.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Dogs; Epoprostenol; Female; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors | 1991 |
Effect of a thromboxane A2 synthetase inhibitor (OKY-046.HCl) on airway hyperresponsiveness in guinea pigs.
Topics: 6-Ketoprostaglandin F1 alpha; Acetylcholine; Airway Resistance; Animals; Antigens; Aspirin; Bronchoalveolar Lavage Fluid; Guinea Pigs; Leukotriene E4; Methacrylates; N-Formylmethionine Leucyl-Phenylalanine; Phthalazines; Physostigmine; Platelet Activating Factor; Propranolol; Respiratory System; SRS-A; Thromboxane B2; Thromboxane-A Synthase | 1990 |
The role of prostanoids in the production of acute acalculous cholecystitis by platelet-activating factor.
Topics: 6-Ketoprostaglandin F1 alpha; Absorption; Acute Disease; Animals; Body Water; Cats; Cholecystitis; Gallbladder; Hemodynamics; Indomethacin; Peroxidase; Platelet Activating Factor; Prostaglandins; Prostaglandins E | 1990 |
Endotoxin-induced myocardial depression in rats: effect of ibuprofen and SDZ 64-688, a platelet activating factor receptor antagonist.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Body Weight; Depression, Chemical; Endotoxins; Escherichia coli; Heart Rate; Ibuprofen; In Vitro Techniques; Lipopolysaccharides; Male; Myocardial Contraction; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1990 |
Effects of the protein kinase inhibitors, staurosporine and K-252a, on PGI2 production by rat liver cells (the C-9 cell line).
Topics: 6-Ketoprostaglandin F1 alpha; Alkaloids; Animals; Calcimycin; Carbazoles; Cell Line; Drug Synergism; Epoprostenol; Indole Alkaloids; Liver; Platelet Activating Factor; Protein Kinase C; Radioimmunoassay; Rats; Staurosporine; Tetradecanoylphorbol Acetate | 1990 |
Endothelin-1 and platelet activating factor stimulate thromboxane A2 biosynthesis in rat vascular smooth muscle cells.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Calcium; Cells, Cultured; Dexamethasone; Endothelins; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Rats; Rats, Inbred Strains; Thromboxane A2; Thromboxane B2 | 1990 |
Evidence for an intracellular action of platelet-activating factor in bovine cultured aortic endothelial cells.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta, Thoracic; Azepines; Bradykinin; Calcimycin; Cattle; Cells, Cultured; Endothelium, Vascular; Platelet Activating Factor; Triazines; Triazoles | 1989 |
Prostaglandin production by cultured cynomolgus monkey trabecular meshwork cells.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Bradykinin; Calcimycin; Cells, Cultured; Dexamethasone; Dinoprost; Dinoprostone; Humans; Macaca fascicularis; Platelet Activating Factor; Prostaglandins; Radioimmunoassay; Trabecular Meshwork | 1989 |
Selenium deficiency inhibits prostacyclin release and enhances production of platelet activating factor by human endothelial cells.
Topics: 6-Ketoprostaglandin F1 alpha; Arachidonic Acid; Arachidonic Acids; Calcium; Cells, Cultured; Endothelium, Vascular; Epoprostenol; Glutathione Peroxidase; Histamine; Humans; Inositol 1,4,5-Trisphosphate; Platelet Activating Factor; Selenium; Thrombin; Umbilical Veins | 1989 |
Relaxant effect of N-formyl-methionyl-leucyl-phenylalanine on rabbit vascular strips.
Topics: 6-Ketoprostaglandin F1 alpha; Acetylcholine; Animals; Complement C5; Complement C5a; In Vitro Techniques; Leukotriene B4; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Rabbits; Vasodilation | 1989 |
Equine peritoneal macrophage production of thromboxane and prostacyclin in response to platelet activating factor and its receptor antagonist SRI 63-441.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Calcimycin; Endotoxins; Epoprostenol; Escherichia coli; Female; Horses; Macrophages; Male; Peritoneal Cavity; Platelet Activating Factor; Platelet Membrane Glycoproteins; Quinolinium Compounds; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thromboxane A2; Thromboxane B2 | 1989 |
Phospholipase A2-mediated release of arachidonic acid in stimulated guinea pig alveolar macrophages: interaction with lipid mediators and cyclic AMP.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acids; Bronchoalveolar Lavage Fluid; Calcimycin; Cyclic AMP; Dinoprostone; Guinea Pigs; Lipid Metabolism; Lipids; Macrophages; N-Formylmethionine Leucyl-Phenylalanine; Phospholipases; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Pulmonary Alveoli; Tetradecanoylphorbol Acetate; Thromboxane B2 | 1989 |
Intracellular platelet-activating factor regulates eicosanoid generation in guinea-pig resident peritoneal macrophages.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Arachidonic Acids; Azepines; Calcimycin; Chromatography, High Pressure Liquid; Culture Media; Dinoprostone; Eicosanoids; Guinea Pigs; In Vitro Techniques; Macrophages; Male; N-Formylmethionine Leucyl-Phenylalanine; Peritoneal Cavity; Platelet Activating Factor; Superoxides; Triazines; Triazoles | 1989 |
CV 6209 is a non-competitive antagonist of platelet-activating factor receptors on guinea-pig resident peritoneal macrophages.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Calcimycin; Epoprostenol; Guinea Pigs; In Vitro Techniques; Macrophages; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Peritoneal Cavity; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Pyridinium Compounds; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1989 |
The effects of platelet-activating factor on flow rate and eicosanoid release in the isolated perfused rat gastric vascular bed.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Benzofurans; Blood Flow Velocity; Chromatography, High Pressure Liquid; Chromones; Diterpenes; Gastric Mucosa; Ginkgolides; Indomethacin; Lactones; Lipoxygenase Inhibitors; Male; Masoprocol; Platelet Activating Factor; Rats; Rats, Inbred Strains; SRS-A; Stomach; Thromboxane B2 | 1989 |
Inhibition of the release of prostaglandins, thromboxanes, and leukotrienes from anaphylactic lungs by a platelet-activating factor (PAF) antagonist and its stimulation by PAF.
Topics: 6-Ketoprostaglandin F1 alpha; Anaphylaxis; Animals; Dinoprostone; Fatty Acids, Unsaturated; Guinea Pigs; In Vitro Techniques; Leukotriene B4; Lung; Platelet Activating Factor; Prostaglandins E; SRS-A; Thromboxane B2 | 1987 |
SOD prevents damage and attenuates eicosanoid release in a rabbit model of necrotizing enterocolitis.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Depression, Chemical; Dinoprostone; Disease Models, Animal; Enterocolitis, Pseudomembranous; Leukotriene B4; Leukotrienes; Male; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Prostaglandins; Rabbits; Superoxide Dismutase; Thromboxane B2 | 1988 |
Platelet-activating factor stimulates arachidonic acid metabolism in rat liver cells (C-9 cell line) by a receptor-mediated mechanism.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Arachidonic Acids; Carcinogens; Cell Line; Liver; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1988 |
Circulatory effects of PAF-acether in newborn piglets.
Topics: 6-Ketoprostaglandin F1 alpha; Acetophenones; Animals; Animals, Newborn; Bridged Bicyclo Compounds, Heterocyclic; Fatty Acids, Unsaturated; Hemodynamics; Hydrazines; Indomethacin; Platelet Activating Factor; Pulmonary Circulation; Pulmonary Wedge Pressure; Swine; Tetrazoles; Thromboxane B2; Vascular Resistance | 1989 |
Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors.
Topics: 6-Ketoprostaglandin F1 alpha; Adrenergic alpha-Antagonists; Animals; Arteriosclerosis; Coronary Circulation; Coronary Disease; Dogs; Hemodynamics; Imidazoles; Male; Platelet Activating Factor; Platelet Aggregation; Serotonin Antagonists; Thromboxane B2 | 1985 |
PAF-acether-induced synthesis of prostacyclin by human endothelial cells.
Topics: 6-Ketoprostaglandin F1 alpha; Arachidonic Acid; Arachidonic Acids; Cells, Cultured; Endothelium; Epoprostenol; Humans; Phospholipids; Platelet Activating Factor; Radioimmunoassay; von Willebrand Factor | 1986 |
Vasodepressor phospholipids in reversal of renal hypertension.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antihypertensive Agents; Arachidonic Acid; Arachidonic Acids; Blood Pressure; Dinoprostone; Hypertension, Renovascular; Phospholipases A; Phospholipids; Platelet Activating Factor; Prostaglandins E; Rats | 1987 |
Effects of platelet-activating factor on coronary hemodynamics and coronary venous plasma levels of TXB2, 6-keto-PGF1 alpha, and leukotriene C4 immunoreactivity in the intact domestic pig heart.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Coronary Circulation; Heart; Myocardium; Platelet Activating Factor; SRS-A; Swine; Thromboxane B2; Thromboxanes | 1985 |
Active immunization induces lung hyperresponsiveness in the guinea pig. Pharmacologic modulation and triggering role of the booster injection.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Bronchial Spasm; Capillary Permeability; Female; Guinea Pigs; Histamine; Immunization; Immunization, Secondary; Kinetics; Lung; Male; Ovalbumin; Perfusion; Platelet Activating Factor; Pulmonary Circulation; Respiratory Hypersensitivity; SRS-A; Thromboxane B2 | 1988 |
Influence of prostaglandins and PG-analogues on the mortality of PAF-acether in mice and the TXB2 release from human granulocytes.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Dinoprost; Granulocytes; Humans; In Vitro Techniques; Mice; Mice, Inbred Strains; Platelet Activating Factor; Prostaglandins; Prostaglandins, Synthetic; Skin; Species Specificity; Thromboxane B2 | 1988 |
The effect of dietary fish oil and long-term salt loading on blood pressure and eicosanoid metabolism in spontaneously hypertensive rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Pressure; Body Weight; Chromatography, Gas; Diet; Eicosanoids; Fatty Acids, Nonesterified; Fish Oils; Hypertension; Male; Platelet Activating Factor; Potassium; Rats; Rats, Inbred SHR; Sodium; Thromboxane B2; Urodynamics | 1988 |
Pulmonary vascular response to platelet-activating factor in conscious sheep.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Pressure; Cardiac Output; Lymph; Methacrylates; Platelet Activating Factor; Pulmonary Circulation; Reference Values; Sheep; Thromboxane B2; Thromboxane-A Synthase; Vascular Resistance | 1988 |
Pharmacological modulation of PAF-acether-induced pleurisy in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcium Channel Blockers; Exudates and Transudates; Glucocorticoids; Male; Platelet Activating Factor; Pleurisy; Rats; Rats, Inbred Strains; SRS-A; Thromboxane B2; Time Factors; Vasodilator Agents | 1987 |
Increased aortic PGI2 and plasma lyso-PAF in the unclipped one-kidney hypertensive rat.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta; Blood Pressure; Epoprostenol; Hypertension, Renovascular; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1986 |
Cardiac and coronary consequences of intracoronary platelet activating factor infusion in the domestic pig.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Coronary Circulation; Coronary Vessels; Female; Heart; Indomethacin; Infusions, Intra-Arterial; Male; Nitroprusside; Platelet Activating Factor; SRS-A; Swine; Thromboxane A2 | 1987 |
Exudative, cellular and humoral reactions to platelet-activating factor (PAF-acether) in the pleural cavity of rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Histamine; Kinetics; Leukocyte Count; Male; Platelet Activating Factor; Pleural Effusion; Rats; Rats, Inbred Strains; SRS-A; Thromboxane B2 | 1986 |
Inhibition by AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonyl methoxy coumarin) of platelet aggregation in dog stenosed coronary artery.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Animals; Chromonar; Collagen; Coronary Disease; Coumarins; Disease Models, Animal; Dogs; Epinephrine; Male; Platelet Activating Factor; Platelet Aggregation; Regional Blood Flow; Thromboxane B2 | 1985 |
Effects of platelet-activating factor on the release of arachidonic acid and prostaglandins by rabbit iris smooth muscle. Inhibition by calcium channel antagonists.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Arachidonic Acids; Calcium; Calcium Channel Blockers; Dinoprostone; Dose-Response Relationship, Drug; Female; Iris; Male; Microsomes; Muscle, Smooth; Phosphatidylinositols; Platelet Activating Factor; Prostaglandins; Prostaglandins E; Rabbits; Time Factors | 1985 |
Platelet-activating factor causes pulmonary vasoconstriction and edema via platelet-independent leukotriene formation.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Platelets; Edema; Lung; Male; Platelet Activating Factor; Pulmonary Circulation; Rats; Rats, Inbred Strains; SRS-A; Vasoconstriction | 1983 |
Platelet-activating factor raises airway and vascular pressures and induces edema in lungs perfused with platelet-free solution.
Topics: 6-Ketoprostaglandin F1 alpha; Airway Resistance; Animals; Blood Platelets; Female; Guinea Pigs; Indomethacin; Lung; Perfusion; Platelet Activating Factor; Pressure; Pulmonary Edema; Thromboxane B2; Vascular Resistance | 1984 |
Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Pressure; Dogs; Electrocardiography; Endotoxins; Heart; Heart Rate; Myocardium; Oxygen Consumption; Platelet Activating Factor; Shock; Thromboxane B2 | 1983 |
Inhibition of carrageenin-induced rat paw oedema by crotapotin, a polypeptide complexed with phospholipase A2.
Topics: 6-Ketoprostaglandin F1 alpha; Administration, Oral; Animals; Arachidonic Acid; Carrageenan; Cell Degranulation; Crotoxin; Disease Models, Animal; Edema; Guinea Pigs; Histamine Release; Humans; Injections, Intraperitoneal; Male; Mast Cells; p-Methoxy-N-methylphenethylamine; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Platelet Aggregation; Rats; Rats, Wistar; Serotonin; Thromboxane B2 | 1995 |
Relevance of mediators to cardiac parameters of isolated anaphylactic guinea-pig heart.
Topics: 6-Ketoprostaglandin F1 alpha; Anaphylaxis; Animals; Catecholamines; Eicosanoids; Epinephrine; Guinea Pigs; Heart; Histamine Release; Kinetics; Leukotrienes; Male; Norepinephrine; Ovalbumin; Platelet Activating Factor; Thromboxane B2 | 1995 |
Nicotine inhibits cytokine synthesis by mouse colonic mucosa.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Colitis, Ulcerative; Colon; Cytokines; Dinoprostone; Female; Interleukin-1; Intestinal Mucosa; Leukotriene B4; Leukotriene C4; Mice; Mice, Inbred BALB C; Nicotine; Platelet Activating Factor; Prostaglandins; Thromboxane B2; Tumor Necrosis Factor-alpha | 1995 |
[Septic shock and multiple organ failure in surgical intensive care. An animal experiment model on the analysis of pulmonary and intestinal dysfunction].
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Critical Care; Epoprostenol; Escherichia coli Infections; Hemodynamics; Interleukin-6; Intestinal Mucosa; Intestines; Ion Channels; Ischemia; Lung; Microscopy, Electron; Multiple Organ Failure; Platelet Activating Factor; Postoperative Complications; Potassium; Pulmonary Gas Exchange; Respiratory Distress Syndrome; Shock, Septic; Swine; Thromboxane A2; Tumor Necrosis Factor-alpha | 1993 |
Stimulation of angiogenesis by substance P and interleukin-1 in the rat and its inhibition by NK1 or interleukin-1 receptor antagonists.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Histamine; Histamine H1 Antagonists; Histamine H2 Antagonists; Indomethacin; Inflammation; Interleukin-1; Male; Neovascularization, Pathologic; Neurokinin-1 Receptor Antagonists; Platelet Activating Factor; Prostaglandins; Rats; Rats, Wistar; Receptors, Interleukin-1; Receptors, Neurokinin-1; Regional Blood Flow; Substance P; Xenon Radioisotopes | 1993 |
Platelet-activating factor mediates trinitrobenzene induced colitis.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Azepines; Colitis; Colon; Dinoprostone; Eicosanoids; Gastrointestinal Contents; Leukotriene B4; Platelet Activating Factor; Rabbits; Second Messenger Systems; Thromboxane B2; Triazoles; Trinitrobenzenesulfonic Acid | 1994 |
Ketotifen and nitroxides decrease capsaicin-augmented ethanol-induced gastric damage in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Capsaicin; Cyclic N-Oxides; Ethanol; Free Radical Scavengers; Free Radicals; Gastric Mucosa; Ketotifen; Leukotriene B4; Leukotriene C4; Male; Mast Cells; Nerve Fibers; Platelet Activating Factor; Premedication; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Spin Labels; Stomach Ulcer | 1995 |
Effect of platelet activating factor antagonist (CV-3988) on 6-keto-PGF1 alpha and thromboxane B2 in dogs with experimental endotoxin-induced shock.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Dog Diseases; Dogs; Hemodynamics; Phospholipid Ethers; Platelet Activating Factor; Shock, Septic; Thromboxane B2 | 1995 |
Haemodynamic and haematologic effects of Acanthaster planci venom in dogs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Cells; Blood Pressure; Cardiac Output; Cyclooxygenase Inhibitors; Dogs; Dose-Response Relationship, Drug; Female; Hemodynamics; Hypotension; Indomethacin; Injections, Intravenous; Leukopenia; Lipoxygenase Inhibitors; Male; Platelet Activating Factor; Starfish; Tachyphylaxis; Thrombocytopenia; Vascular Resistance; Venoms | 1994 |
The effect of Clostridium difficile toxin on colonocyte prostanoid activity.
Topics: 6-Ketoprostaglandin F1 alpha; Bacterial Proteins; Bacterial Toxins; Cell Line, Transformed; Colon; Culture Media; Cyclooxygenase Inhibitors; Dexamethasone; Dinoprostone; Enterotoxins; Enzyme-Linked Immunosorbent Assay; Humans; Indomethacin; Leukotriene B4; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Thromboxane B2 | 1994 |
Inflammatory chemical mediators during conventional ventilation and during high frequency oscillatory ventilation.
Topics: 6-Ketoprostaglandin F1 alpha; Analysis of Variance; Animals; Bronchoalveolar Lavage Fluid; High-Frequency Ventilation; Inflammation Mediators; Leukocyte Count; Lung Compliance; Male; Neutrophils; Platelet Activating Factor; Pulmonary Surfactants; Rabbits; Respiration, Artificial; Thromboxane B2 | 1994 |
Eicosanoid and inositol phosphate response to platelet-activating factor (PAF) and to a PAF antagonist in rat astroglial cells.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Animals, Newborn; Astrocytes; Calcimycin; Cells, Cultured; Diterpenes; Dose-Response Relationship, Drug; Eicosanoids; Ginkgolides; Inositol; Inositol Phosphates; Kinetics; Lactones; Platelet Activating Factor; Rats; Thromboxane B2 | 1994 |
Synthesis and release of platelet-activating factor and eicosanoids in human endothelial cells induced by different agonists.
Topics: 6-Ketoprostaglandin F1 alpha; Arachidonic Acid; Blood Platelets; Calcimycin; Cells, Cultured; Dinoprostone; Endothelins; Endothelium, Vascular; Epoprostenol; Histamine; Humans; Hydroxyeicosatetraenoic Acids; Interleukin-1; Platelet Activating Factor; Platelet Aggregation; Prostaglandins; Serotonin; Thrombin; Tumor Necrosis Factor-alpha; Umbilical Veins | 1993 |
Platelet-activating factor as a vasodepressive mediator of liver ischemia.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Ischemia; Isoquinolines; Liver; Male; Molecular Structure; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Wistar; Tetrahydroisoquinolines; Thromboxane B2 | 1993 |
Lipid mediator production in acute and chronic pancreatitis in the rat.
Topics: 6-Ketoprostaglandin F1 alpha; Acute Disease; Animals; Chronic Disease; Dinoprostone; Diterpenes; Eicosanoids; Ginkgolides; Lactones; Leukotriene B4; Ligation; Male; Masoprocol; Pancreatic Ducts; Pancreatitis; Platelet Activating Factor; Prostaglandin D2; Rats; Rats, Sprague-Dawley; Taurocholic Acid; Thromboxane B2 | 1994 |
Platelet activating factor enhances receptor-operated Ca(++)-influx and subsequent prostacyclin synthesis in human endothelial cells.
Topics: 6-Ketoprostaglandin F1 alpha; Calcium; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Epoprostenol; Fura-2; Histamine; Humans; Imidazoles; Kinetics; Platelet Activating Factor; Platelet Aggregation Inhibitors; Spectrometry, Fluorescence; Thrombin; Umbilical Veins | 1993 |
Metabolism of arachidonic acid by caruncular and allantochorionic tissues in cows with retained fetal membranes (RFM).
Topics: 6-Ketoprostaglandin F1 alpha; Allantois; Animals; Arachidonic Acid; Calcium; Cattle; Chorion; Chromatography, High Pressure Liquid; Dinoprost; Dinoprostone; Epidermal Growth Factor; Female; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Oxytocin; Placenta; Placenta Diseases; Platelet Activating Factor; Pregnancy; Thromboxane B2 | 1993 |
Effect of 5-lipoxygenase and cyclooxygenase blockade on porcine hemodynamics during continuous infusion of platelet-activating factor.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Azepines; Blood; Calcimycin; Chromatography, High Pressure Liquid; Cyclooxygenase Inhibitors; Hemodynamics; Hypertension, Pulmonary; In Vitro Techniques; Indomethacin; Infusions, Intra-Arterial; Leukotriene B4; Lipoxygenase Inhibitors; Naphthoquinones; ortho-Aminobenzoates; Platelet Activating Factor; Swine; Thromboxane B2; Triazoles | 1993 |
Platelet activating factor (PAF) stimulates release of PGI2 from inflamed rabbit gallbladder cell cultures.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antibodies; Cells, Cultured; Cholecystitis; Cytochrome P-450 Enzyme System; Dinoprost; Dose-Response Relationship, Drug; Epoprostenol; Gallbladder; Immunoblotting; Indomethacin; Intramolecular Oxidoreductases; Isomerases; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Proteins; Rabbits; Thromboxane B2 | 1995 |
Cyclooxygenase-2-dependent bronchoconstriction in perfused rat lungs exposed to endotoxin.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 6-Ketoprostaglandin F1 alpha; Animals; Bronchoconstriction; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; DNA Primers; Endotoxins; Female; In Vitro Techniques; Isoenzymes; Lipopolysaccharides; Lipoxygenase Inhibitors; Lung; Microscopy, Electron, Scanning; Platelet Activating Factor; Polymerase Chain Reaction; Prostaglandin Endoperoxides, Synthetic; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; RNA, Messenger; Salmonella; Thromboxane A2; Thromboxane B2; Transcription, Genetic; Vasoconstrictor Agents | 1996 |
Effects of platelet-activating factor antagonist E5880 on intrahepatic and systemic metabolic responses to transient hepatic inflow occlusion and reperfusion in the rabbit.
Topics: 6-Ketoprostaglandin F1 alpha; Adenine Nucleotides; Ammonia; Analysis of Variance; Animals; Blood Gas Analysis; Blood Glucose; Energy Metabolism; Hydrogen-Ion Concentration; Lactic Acid; Liver; Male; Piperidines; Platelet Activating Factor; Pyridinium Compounds; Pyruvic Acid; Rabbits; Reperfusion Injury; Thromboxane B2 | 1996 |
Surface coverage of vascular grafts with cultured human endothelial cells from subcutaneous fat tissue obtained with a biopsy needle.
Topics: 6-Ketoprostaglandin F1 alpha; Adipose Tissue; Biopsy, Needle; Blood Vessel Prosthesis; Cell Separation; Cells, Cultured; Endothelin-1; Endothelium, Vascular; Humans; Microcirculation; Platelet Activating Factor; Surface Properties | 1996 |
Influence of heat shock protein 70 and metallothionein induction by zinc-bis-(DL-hydrogenaspartate) on the release of inflammatory mediators in a porcine model of recurrent endotoxemia.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspartic Acid; Blood Pressure; Cardiac Output; Disease Models, Animal; Endotoxemia; Gene Expression; HSP70 Heat-Shock Proteins; Inflammation Mediators; Interleukin-1; Interleukin-6; Kidney; Lipopolysaccharides; Metallothionein; Platelet Activating Factor; Pulmonary Artery; Recurrence; Swine; Thromboxane B2; Tumor Necrosis Factor-alpha; Zinc | 1996 |
Non-specific PAF binding to embryonal F9 cells and prostacyclin synthesis in human umbilical vein endothelial cells.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Azepines; Carcinoma, Embryonal; Cell Line; Embryo, Mammalian; Endothelium, Vascular; Epoprostenol; Humans; Mice; Neoplasms, Germ Cell and Embryonal; Platelet Activating Factor; Platelet Aggregation Inhibitors; Triazoles; Umbilical Veins | 1996 |
Expression of acute otitis media after receptor blockade of platelet activating factor, thromboxane, and leukotrienes in the chinchilla.
Topics: 6-Ketoprostaglandin F1 alpha; Acute Disease; Animals; Azepines; Biphenyl Compounds; Chinchilla; Dinoprostone; Ear, Middle; Fatty Acids, Nonesterified; Heptanoic Acids; Hydrolases; Leukotriene Antagonists; Leukotriene C4; Mucous Membrane; Otitis Media; Phospholipids; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pneumococcal Infections; Propionates; Quinolines; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Thromboxane; Thromboxane B2; Triazoles | 1998 |
[The effect of platelet activating factor on the biosynthesis of thromboxane A2 and prostaglandin I2 in human placental villi and umbilical artery].
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Chorionic Villi; Epoprostenol; Female; Humans; Platelet Activating Factor; Pregnancy; Thromboxane A2; Umbilical Arteries | 1997 |
Are lipid mediators implicated in the production of pro- and anti-inflammatory cytokines during cardiopulmonary bypass graft with extracorporeal circulation?
Topics: 6-Ketoprostaglandin F1 alpha; Anti-Inflammatory Agents; Cardiopulmonary Bypass; Cytokines; Dinoprostone; Extracorporeal Circulation; Humans; Inflammation Mediators; Interleukin-10; Interleukin-4; Interleukin-6; Interleukin-8; Leukotriene B4; Leukotriene C4; Lipid Metabolism; Lipids; Multiple Organ Failure; Platelet Activating Factor; Prospective Studies; Thromboxane B2; Tumor Necrosis Factor-alpha | 1999 |
Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Capillary Leak Syndrome; Capillary Permeability; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cysteine; Diterpenes; Eicosanoids; Enzyme Induction; Ginkgolides; Histamine Release; Indoles; Indomethacin; Isoenzymes; Lactones; Leukotriene C4; Leukotrienes; Lipoxygenase Inhibitors; Macrophages, Peritoneal; Male; Mast Cells; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Mutant Strains; Nitrobenzenes; Peritonitis; Phospholipid Ethers; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Quinolines; Sulfonamides; Thioglycolates; Zymosan | 2002 |